Last Updated: June 17, 2026

ZINC CHLORIDE IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Zinc Chloride In Plastic Container, and when can generic versions of Zinc Chloride In Plastic Container launch?

Zinc Chloride In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in ZINC CHLORIDE IN PLASTIC CONTAINER is zinc chloride. There are thirty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the zinc chloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zinc Chloride In Plastic Container

A generic version of ZINC CHLORIDE IN PLASTIC CONTAINER was approved as zinc chloride by EXELA PHARMA on May 21st, 2021.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ZINC CHLORIDE IN PLASTIC CONTAINER?
  • What are the global sales for ZINC CHLORIDE IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for ZINC CHLORIDE IN PLASTIC CONTAINER?
Summary for ZINC CHLORIDE IN PLASTIC CONTAINER
US Patents:0
Applicants:1
NDAs:1

US Patents and Regulatory Information for ZINC CHLORIDE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira ZINC CHLORIDE IN PLASTIC CONTAINER zinc chloride INJECTABLE;INJECTION 018959-001 Jun 26, 1986 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Summary
Zinc chloride in plastic containers presents a niche but potentially stable pharmaceutical product. Its investment attractiveness depends on market demand driven by applications in medicine, galvanization, and chemical synthesis, balanced against manufacturing, regulatory, and competitive risks. Analyzing fundamentals reveals a need for assessing patent statuses, manufacturing costs, regulatory environment, and end-use markets.

What Is the Market for Zinc Chloride in Pharmaceuticals and Related Industries?

Zinc chloride is used in various sectors. In pharmaceuticals, it functions as a topical antiseptic, a component in oral hygiene products, and in wound care, often as an ingredient in topical solutions. The broader chemicals market uses zinc chloride in galvanization, rubber manufacturing, and as a flux in soldering.

Estimated global zinc chloride market size was approximately USD 250 million in 2022, growing at a CAGR of 4-5% through 2028 [1]. The pharmaceutical sector constitutes a niche subset, likely representing under 10% of the total, with application volume driven by demand for antiseptics and other topical formulations.

Key demand drivers:

Last updated: February 5, 2026

  • Rising demand for antiseptic products, especially in response to COVID-19 and increased hygiene awareness.
  • Growth in wound care markets.
  • Expansion of industrial uses, notably in galvanization and chemical synthesis.

What Are the Regulatory and Patent Considerations?

Existing patents for zinc chloride formulations vary by region but tend to expire or have expired for standard compositions used as antiseptics. New formulations, delivery methods, or combined products could be patentable, affecting exclusivity. Regulatory approval hinges on compliance with agencies such as the FDA (U.S.), EMA (Europe), and others, which usually require demonstrating safety, purity, and efficacy for pharmaceutical uses.

In countries with strict regulatory environments, approval timelines can span 1-3 years, with costs for clinical testing and submission fees. No recent patent litigations or renewals are typically associated specifically with zinc chloride in formulations, but competitors may patent downstream applications or delivery systems.

How Do Manufacturing and Supply Chain Factors Impact Investment?

Manufacturing costs for zinc chloride depend on:

  • Raw material costs for zinc and chlorine.
  • Purification processes to meet pharmaceutical-grade standards.
  • Packaging suitability for plastic containers; stability considerations over shelf life.

Capital and operational expenditures vary with scale. Contract manufacturing organizations (CMOs) with quality certifications (e.g., cGMP, ISO 13485) manage production. Supply chain risks include raw material sourcing, especially as zinc prices fluctuate, and quality assurance to prevent contamination.

Shelf life of zinc chloride solutions in plastic containers is generally 2-3 years when stored properly, influencing inventory turnover and packaging choices.

What Are Competitive and Market Entry Barriers?

The market features established global suppliers, including companies specializing in pharmaceutical-grade chemicals. Entry barriers include:

  • Regulatory approvals.
  • Manufacturing scale and quality standards.
  • Existing long-term contracts between incumbent suppliers and large pharmaceutical companies.

Differentiation strategies focus on sourcing stability, product purity, and cost competitiveness. Vertical integration or exclusive distribution agreements could also influence market entry.

Financial Considerations and Investment Risks

Investment attractiveness relies on:

  • Market size and growth potential.
  • Regulatory clearance timelines.
  • Cost of production and scalability.
  • Competitive landscape.

Risks involve regulatory delays, raw material price volatility, possible substitution by alternative antiseptics (e.g., povidone-iodine, alcohol-based products), and patent issues for novel formulations.

Forecasts must factor in the ongoing demand in antiseptic applications, potential for new uses, and technological innovations that could alter competitive dynamics.

Key Takeaways

  • The global zinc chloride market is approximately USD 250 million, with pharmaceutical applications comprising a small, steady segment.
  • Growth driven by demand in antiseptic, wound care, and industrial sectors.
  • Regulatory pathways demand compliance with safety and efficacy standards; patent landscape varies.
  • Manufacturing costs depend on raw materials, quality standards, and packaging considerations.
  • Competition from established suppliers and technological barriers limit market entry; differentiation hinges on product purity and supply chain stability.
  • Investment hinges on market growth, regulatory timelines, and cost management, with risks from substitute products and raw material price fluctuations.

FAQs

1. What is the primary pharmaceutical use of zinc chloride?
It is mainly used as an antiseptic in topical formulations and in oral hygiene products.

2. How long is zinc chloride stable in plastic containers?
Typically, 2 to 3 years when stored in proper conditions.

3. Are there significant patent barriers for zinc chloride formulations?
Standard formulations are generally off-patent; however, new delivery systems or combination drugs may require patent considerations.

4. What are key factors affecting manufacturing costs?
Raw material prices for zinc and chlorine, production purity standards, and packaging quality.

5. What are main competitors in this market segment?
Global chemical suppliers with established pharmaceutical-grade zinc chloride products, such as Merck, Sigma-Aldrich, and local chemical producers.

References:
[1] MarketsandMarkets, "Zinc Chloride Market Size, Share & Trends," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.